ArticleAIDS and behavior2026
Prevalence and Correlates of Non-Alcoholic Beverage Consumption Among People Living with HIV: A Potential Alcohol Reduction Strategy.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Unhealthy alcohol use is prevalent among people living with HIV (PLH) and is associated with worse HIV care outcomes. Non-alcoholic beverages (NABs; beer, wine, or spirits containing 0.0% to 0.5% alcohol by volume) may represent a novel alcohol reduction strategy; however, the prevalence and correlates of NAB use among PLH remain unexamined. This study utilized baseline data from the Florida Cohort Study (N = 589; June 2024-October 2025). Self-report measures assessed past 12-month NAB consumption and likelihood of future NAB use. Multivariable logistic regression models examined sociodemographic and health-related correlates of past-year NAB consumption and future use. Overall, 26.83% of participants consumed NABs in the past 12 months; 18.34% were likely or extremely likely to use NABs in the future. In multivariable analyses, higher odds of past-year NAB consumption were associated with identifying as Non-Hispanic Black (AOR = 3.10, 95% CI: 1.77-5.42 vs. Non-Hispanic White) or Latine (AOR = 2.57, 95% CI: 1.36-4.86 vs. Non-Hispanic White), lesbian, gay, bisexual, or queer (AOR = 1.74, 95% CI: 1.14-2.64 vs. straight/heterosexual), and moderate/high risk of alcohol use disorder (AUD) (AOR = 2.43, 95% CI: 1.39-4.23 vs. no/low risk). Similar patterns were observed for future likelihood to use NABs. Approximately one-quarter of PLH reported past 12-month NAB consumption, although relatively fewer expressed interest in future use. NABs may represent a promising, yet underutilized, alcohol reduction strategy for PLH; however, additional research is needed to understand motivations, contexts of use, and impacts on alcohol-related and HIV outcomes.
Indexed as
Identifiers
42766201What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.